Page 220 - Multidisipliner Covid 19
P. 220

BÖLÜM  12






          KAYNAKLAR


          1.  Fauci AS, Lane HC, Redfield RR. Covid-19 - navigating the uncharted.
             N Engl J Med. 2020;382(13):1268–9.
          2. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic
             treatments for coronavirus disease 2019 (COVID-19) a review. JAMA.
             2020. https://doi.org/10.1001/jama.2020.6019. [Epub ahead of print].
          3.  Clinical management of severe acute respiratory infection when COVID-
             19 is suspected 2020 [Internet]. World Health Organization [erişim 31
             Mart 2020]. https://www.who.int/publications-detail/clinical- manage-
             ment-of-severe-acute-respiratory-infection-when-novel-coronavirus-
             (ncov)-infection-is-suspected.
          4.  Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society
             of America guidelines on the treatment and Management of Patients
             with COVID-19 [Internet] [erişim 11 Mayıs 2020].https://www.idsociety.org/
             practice-guideline/covid-19- guideline-treatment-and-management/.
          5.  COVID-19 Rehberi [Internet]. T.C. Sağlık Bakanlığı [erişim 25 Mayıs
             2020]. https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID19_
             Rehberi.pdf?type=file.
          6.  Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chlo-
             roquine on viral infections: an old drug against today’s diseases? Lan-
             cet Infect Dis. 2003;3(11):722-727. doi:10.1016/S1473-3099(03) 00806-5.
          7.  Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively
             inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
             Cell Res. 2020;30(3):269–71.
          8.  Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of
             optimized dosing Design of Hydroxychloroquine for the treatment of
             severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin
             Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa237.
          9.  Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine
             the effect of hydroxychloroquine in preventing infection and progres-
             sion. [published online March 20, 2020]. J Antimicrob Chemother. 2020;
             dkaa114. doi:10. 1093/jac/dkaa114;
          10. Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antivi-
             ral effects of chloroquine against coronavirus: what to expect for COV-
             ID-19? Int J Antimicrob Agents. 2020; 105938. doi:10.1016/j. ijantimicag.
             2020.105938.




                                                                        219
   215   216   217   218   219   220   221   222   223   224   225